Search filters

List of works by Elisabetta Patorno

A tool for empirical equipoise assessment in multigroup comparative effectiveness research

scientific article published on 27 May 2019

COMPARATIVE PERFORMANCE OF FOUR CLAIMS-BASED FRAILTY MEASURES IN THE UNITED STATES MEDICARE DATA

scholarly article in Innovation in Aging, vol. 3, Suppl 1, November 2019

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study

scientific article published on 6 February 2018

Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care

scientific article published on 01 May 2019

Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.

scientific article published on 5 December 2017

Emulating Randomized Clinical Trials with Nonrandomized Real-World Evidence Studies: First Results from the RCT DUPLICATE Initiative

scientific article published on 17 December 2020

Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making

scientific article published on 09 December 2020

Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset

scientific article published on 01 September 2020

Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data

scientific article published on 29 May 2019

Measuring Frailty in Administrative Claims Data: Comparative Performance of Four Claims-Based Frailty Measures in the United States Medicare Data

scientific article published on 30 September 2019

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid

scientific article published on 23 January 2020

Risk Factors for Heart Failure with Preserved or Reduced Ejection Fraction Among Medicare Beneficiaries: Application of Competing Risks Analysis and Gradient Boosted Model

scientific article published on 15 June 2020

Risk of amputation with canagliflozin across categories of age and cardiovascular risk in three US nationwide databases: cohort study

scientific article published on 25 August 2020

Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings

scientific article published on 30 July 2013

Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments

scientific article published in March 2014

The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care

scientific article published on 26 November 2019

The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States

scientific article published on 24 December 2021

Transparency in real-world evidence (RWE) studies to build confidence for decision-making: Reporting RWE research in diabetes

scientific article published on 01 April 2020

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013-2018

scientific article published on 10 February 2020

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

scientific article published on 25 June 2019

Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.

scientific article